Thanks, Chairman Larry.
I guess I'll go back a couple of small paragraphs. I disregarded the bells. I've been planting soybeans with a tractor the last two weeks. It has more bells and whistles and alarms that go off. I guess I was just driving on here. So I'll just go back two small paragraphs to get back to where I was heading.
Continued investment in Canada by seed companies will result in the development of new varieties through biotechnology, which not only have production advantages for producers but direct consumer benefits as well. Capitalizing on these potential opportunities that can add value to Canadian soybean growers could be put into jeopardy with the introduction of Bill C-474 and place Canada at a competitive disadvantage.
Maintaining our current markets and accessing new markets will continue to be a challenge. Many countries, including Canada, have a zero-tolerance policy regarding unapproved events that are developed through biotechnology. It is impossible for our industry to guarantee zero contamination of any GM trait.
Approval of new GM traits in our key export market establishes thresholds that our industry can meet. In the case that an unapproved GM trait is identified in a Canadian shipment, there is a zero-tolerance policy, and possible action, of course, is the closure of that border.
It is important that Canada's regulatory system remains predictable and science-based. If approval systems in foreign and domestic markets deviate from science-based processes, Canadian soybean growers could face significant delays in new varieties developed through biotechnology becoming commercially available. Canadian soybean growers are currently using varieties that are sometimes at least two years behind our competitors, and this puts us at a competitive disadvantage.
Establishing low-level presence, LLP, agreements with our key export markets and working towards the harmonization of an international approval process for GM traits needs to be a priority to help ensure the competitiveness of Canadian soybean growers.
The Canadian Soybean Council does not support Bill C-474 and recognizes how advances in biotechnology could possibly impact market access. The introduction of the non-science-based criteria to our regulatory system through Bill C-474 is not the answer to ensuring continued access to our important export markets. The Canadian Soybean Council encourages the committee to carefully consider how the future competitiveness of all Canadian farmers will be impacted by this bill. The Canadian Soybean Council believes that government and industry's efforts should focus on negotiating low-level presence agreements with our customer and harmonizing approval processes for GM traits.
I would like to say, however, Mr. Atamanenko, that I think we do have issues in the industry that we have to solve. I think it has been a great forum for dialogue to bring these concerns forward. However, we still do not support Bill C-474.
Thank you, Mr. Chairman.